Nan Shan Life Insurance Co., Ltd. Novo Nordisk A S Transaction History

Nan Shan Life Insurance Co., Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2017 Jun 20, 2018	SELL	N/A	-81,200 Closed	0 $0
Q1 2017 Jun 20, 2018	SELL	N/A	-43,800 Reduced 35.04%	81,200 $2.78 Million
Q4 2016 Jun 20, 2018	SELL	N/A	-531,541 Reduced 80.96%	125,000 $4.48 Million
Q3 2016 Jun 20, 2018	BUY	N/A	536,541 Added 447.12%	656,541 $27.3 Million
Q2 2016 Jun 20, 2018	SELL	N/A	-40,000 Reduced 25.0%	120,000 $6.45 Million
Q3 2015 Jun 20, 2018	BUY	N/A	160,000	160,000 $8.68 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Nan Shan Life Insurance Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Nan Shan Life Insurance Co., Ltd. with notifications on news.